We are live on ! Find out more
PAVMW

PAVmed Inc. Warrant
PAVMW

Delisted

PAVMW was delisted on the 28th of January, 2022.

Back to rankings

2 hedge funds and large institutions have $1K invested in PAVmed Inc. Warrant in 2021 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less capital invested

Capital invested by funds: $278K → $1K (-$277K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$1.14K

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$79.9K
2
AF
Allworth Financial
California
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Wolverine Asset Management
Illinois
$1K -$79.9K -65,785 -88%
AF
2
Allworth Financial
California
– -$1K -400 Closed
UBS Group
3
UBS Group
Switzerland
– +$1.14K +941 +75%

PAVMW Hedge Fund Activity: Q4 2021 in Review

2 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Warrant (PAVMW) for Q4 2021, worth a combined $1K — down 100% from $278K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of PAVMW and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 1 added.

The largest buyer was UBS Group, adding an estimated $1.14K. The largest seller was Wolverine Asset Management, cutting an estimated $79.9K.

  • 2 institutional investors held PAVmed Inc. Warrant (PAVMW) as of Q4 2021, down from 3 in Q3 2021.
  • Funds reported $1K of PAVmed Inc. Warrant stock for Q4 2021, down 100% quarter-over-quarter.
  • 0 funds opened new PAVmed Inc. Warrant positions in Q4 2021 and 1 closed out, a net change of -1 holder.
  • The largest PAVmed Inc. Warrant buyer in Q4 2021 was UBS Group, an estimated $1.14K added.
  • The largest PAVmed Inc. Warrant seller in Q4 2021 was Wolverine Asset Management, an estimated $79.9K sold.

Based on aggregated 13F filings for Q4 2021.